Skip to main content
. 2021 Jun 2;44(6):699–709. doi: 10.1007/s40264-021-01065-z

Fig. 1.

Fig. 1

Histogram of propensity scores for the ustekinumab and non-biologics cohorts; prevalent and incident users in the ever-exposed population (prespecified analyses)